Skip to main content
Birkhäuser

Cystic Fibrosis Pulmonary Infections: Lessons from Around the World

  • Book
  • © 1996

Overview

Part of the book series: Respiratory Pharmacology and Pharmacotherapy (RPP)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (28 chapters)

  1. Cystic Fibrosis Pulmonary Infections: General Aspects

  2. Cystic Fibrosis Pulmonary Infections: The International Perspective

Keywords

About this book

Infection of the lower respiratory tract is a major determinant of the course of cystic fibrosis. Although numerous efforts have been made to elucidate the specific mechanisms predisposing the respiratory mucosa of cystic fibrosis patients to infection, so far no clinically relevant procedures for completely effective prevention or control of infection have resulted. Hence, in dealing with infections in cystic fibrosis, we continue to rely mainly on antimicrobials. Antiinfective measures are inseparably correlated with microbiology, and the quality of antiinfec­ tive therapy directly reflects the quality of microbial monitoring. Vali­ dated guidelines for microbiologic testing and antiinfective use need to be developed and made available to all health providers and their cystic fibrosis patients. Several years ago, the editors cochaired a symposium at the Interna­ tional Congress of Chemotherapy on the Global Perspectives of Micro­ biological and Clinical Infectious Diseases in Patients with Cystic Fibrosis. During this half-day symposium, the editors heard reports from several countries around the world with an alarming range of survival for patients with cystic fibrosis. This sent a dramatic message to us that the understanding of this disease, its diagnosis, management and prevention was different in various countries and that patients may be inconsistently served. That is how our journey began.

Editors and Affiliations

  • Max von Pettenkofer-Institut, Ludwig-Maximilians-Universität, Munich, Germany

    Adolf Bauernfeind

  • University of California at Irvine, Long Beach, USA

    Melvin I. Marks

  • Long Beach Memorial Medical Center, Memorial Miller Children’s Hospital, Long Beach, USA

    Melvin I. Marks

  • Department of Pediatrics, Faculty of Medicine, Göteborg University, Göteborg, Sweden

    Birgitta Strandvik

Bibliographic Information

Publish with us